Northwest Biotherapeutics Inc
NWBO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001072379
No open-market purchases or sales by Northwest Biotherapeutics Inc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $413.6K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Northwest Biotherapeutics Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 354.3K | 825.7K | +471.4K (+133.1%) |
| Value | $453.0K | $576.0K | +$123.0K (+27.2%) |
New holders (3)
Institutions that held Northwest Biotherapeutics Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Estabrook Capital Management | 10,000 | $7.00K | 0.00% |
| Cassady Schiller Wealth Management, LLC | 1,750 | $1.00K | 0.00% |
| Huntington National Bank | 1,250 | $0 | 0.00% |
Sold out (0)
Institutions that held Northwest Biotherapeutics Inc at the end of Q3 2021 and filed for Q4 2021 without it.
None.